Skip to content

Effect of Panchgavya Ghrita and Sarswata Choorna in Chintajanaya Manasika Rog

A COMPARATIVE CLINICAL STUDY OF PANCHGAVYA GHRITA NASYA AND SARSVATA CHOORNA IN THE MANAGEMENT OF CHITTODVEGA W.S.R. TO GENERALIZED ANXIETY DISORDERS - PGG SC

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/12/007521
Enrollment
30
Registered
2016-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- 1) Patients who are fulfilling the DSM IV TR Diagnostic criteria for generalized anxiety disorders

Interventions

Intervention1: Panchgavya ghrita: 8 drops of Panchgavya ghrita in each nostril will be administered for 7days followed by a gap of 7days Like this 4 consecutive courses will be given Control Interv

Sponsors

IPGT and RA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are fulfilling the DSM IV TR Diagnostic criteria for generalized anxiety disorders

Exclusion criteria

Exclusion criteria: Patients presenting with major illness and psychotic disorders Patients below 16 years of age and above 60 years

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action on Signs and Symptoms of chittodweg. Improvement in Hemilton Anxienty Rating Scale, Manasa Parikshya Bhav and Quality of life of Patients.Timepoint: 2) After preliminary registration diagnostic medical history will be taken according to both Ayurveda and modern. Before and after treatment, patients state of anxiety will be assessed by Quality of life scale and Hamilton Anxiety Rating Scale. Along with this scales, various parameter will also be assessed.

Secondary

MeasureTime frame
By providing better effect on General Anxiety Disorder, the drug will effect psychosomatic level of the enrolled patients, enhance quality of life and will contribute in reducing disability adjusted life years. Overall improvement in the disease condition, Quality of Life of the diseased. Based on the observations, the trial drug may be recommended to be added into the Essential Drugs List of Ministry of AYUSH, New DelhiTimepoint: 18 months

Countries

India

Contacts

Public ContactProf PK Prajapati

IPGT RA

anup_thaker@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026